News

INNO4CFI accelerator programme

Published on | 1 month ago

Programmes Agro-Food, Environment EIC

The INNO4CFIs Project has asked NCP Flanders to disseminate their acceleration programme to innovative SMEs and startups. Their acceleration Program is a 3-month, equity-free programme starting in January 2026, designed to support SMEs and startups developing green-tech, carbon farming, and climate-impact solutions. The deadline for application is 2 December 2025 at closing of business.

Selected applicants will benefit from:

  • Tailored, equity-free support through mentoring focused on investment readiness.
  • Connections to investors, suppliers, clients, and insights from diverse European markets.
  • A structured acceleration path from TRL 6+ to TRL 9, enhancing market adoption potential.
  • Access to the Interregional Market Uptake Hub (IMUH) - a pan-European marketplace being developed by the INNO4CFIs connecting solution providers with demand, partners, and investors.
  • Visibility opportunities, including Investor Readiness activities, Demo Day participation, and potential integration into the INNO4CFIs Carbon Farm Technology Platform.

The Programme is open to any green tech Company but it gives priority to carbon farming related technologies, such as: 

  • Regenerative Agriculture
  • Biomass Valorisation & BECCS
  • Automation & Urban Farming
  • Agrivoltaics
  • Aquatic Systems & Irrigation
  • Mineral Carbon Capture
  • MRV
  • Green Finance

Main eligibility Criteria (detailed in the Guidelines for Applicants):

  • SME or Startup established in an EU Member State
  • Green Tech solution with TRL 6 or above

Application form: Via F6S Platform

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1773 articles available search in articles 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.